Results 31 to 40 of about 463,075 (306)

Subclinical lower limb Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus: A cross-sectional study.

open access: yesInternational Journal of Endorsing Health Science Research, 2023
Background: Peripheral artery disease (PAD) is highly prevalent in patients with diabetes mellitus. The ankle-brachial index (ABI) measurement is used to diagnose peripheral arterial disease, and little is known about its prevalence in asymptomatic type
Fahad Naim   +6 more
doaj  

Recent Advances in Peripheral Artery Disease

open access: yesHearts, 2023
Despite its significant impact on patients’ lives and the healthcare system, peripheral arterial disease (PAD) has long been overshadowed by other cardiovascular diseases [...]
Federico Biscetti
doaj   +1 more source

Percutaneous transluminal angioplasty in patients with peripheral arterial disease does not affect circulating monocyte subpopulations [PDF]

open access: yes, 2016
Monocytes are mononuclear cells characterized by distinct morphology and expression of CD14 and CD16 surface receptors. Classical, quiescent monocytes are positive for CD14 (lipopolysaccharide receptor) but do not express Fc gamma receptor III (CD16 ...
Krzanowski, Marek   +5 more
core   +5 more sources

Clinical Profile of Peripheral Artery Disease of Patients Attending Shahid Gangalal National Heart Center, Janakpurdham, Nepal

open access: yesJournal of Nepal Health Research Council
Background: Peripheral artery disease is an important vascular disease. There is an increased incidence of acute limb ischemia in cases of peripheral artery disease. Objective of this study was to assess the prevalence of peripheral artery disease among
Amit Kumar Singh   +3 more
doaj   +1 more source

Association of 6-Minute Walk Performance and Physical Activity With Incident Ischemic Heart Disease Events and Stroke in Peripheral Artery Disease. [PDF]

open access: yes, 2015
BackgroundWe determined whether poorer 6-minute walk performance and lower physical activity levels are associated with higher rates of ischemic heart disease (IHD) events in people with lower extremity peripheral artery disease (PAD).Methods and ...
Criqui, Michael H   +14 more
core   +2 more sources

Clinical and anamnestic characteristics of patients with clinical manifestations of peripheral artery disease as a function of Т(–786)С polymorphism of the endothelial NO-synthase gene promoter [PDF]

open access: yesКардіохірургія та інтервенційна кардіологія, 2016
The aim – to determine the prevalence of Т(–786)С polymorphic gene variants of endothelial NO-synthase (eNOs) in patients with verified atherosclerosis of lower extremities arteries and their association with clinical manifestations of the disease ...
V.I. Tseluyko   +2 more
doaj  

Brachial Artery Constriction during Brachial Artery Reactivity Testing Predicts Major Adverse Clinical Outcomes in Women with Suspected Myocardial Ischemia: Results from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study [PDF]

open access: yes, 2006
Background:Limited brachial artery (BA) flow-mediated dilation during brachial artery reactivity testing (BART) has been linked to increased cardiovascular risk.
Bairey Merz, C. Noel   +5 more
core   +8 more sources

Associations of Weight Change With Changes in Calf Muscle Characteristics and Functional Decline in Peripheral Artery Disease. [PDF]

open access: yes, 2019
Background Among people with lower extremity peripheral artery disease, obesity is associated with faster functional decline than normal weight. The association of weight loss with functional decline in peripheral artery disease is unknown.
Bazzano, Lydia A   +10 more
core  

Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease [PDF]

open access: yes, 2018
BackgroundPeripheral arterial disease (PAD) has a significant negative impact on the quality of life of individuals. Understanding the experiences of people living with PAD will be useful in developing comprehensive patient-centred secondary prevention ...
Abaraogu, Ukachukwu Okoroafor   +3 more
core   +2 more sources

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy